Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes.

NCT02887677 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
85
Enrollment
OTHER
Sponsor class

Stopped On February 2019 Astra-Zeneca Greece decided to stop the financial support of the study.

Conditions

Interventions

Sponsor

Hellenic Society for Medical Education